St. Joseph Medical Center is one of 68 hospitals across the country working to improve this statistic through a protocol established by the National Cardiogenic Shock Initiative Study (NCSI).
“We are the second hospital in the state of Washington to adopt the new protocol,” said Dr. David Zhang, who specializes in cardiac care for adult patients at St. Joseph’s.
This new protocol is the backbone of a groundbreaking clinical trial — funded by global leader in healthcare technology Abiomed — that focuses on implementing best practices to increase survival rates among patients with CS.
NCSI centers around standardized use of Abiomed’s Impella system, the world’s smallest heart pump. While the technology provided by Impella is impressive and helpful on its own, data collected by Abiomed revealed that the way in which Impella is implemented makes a huge difference in its ability to save a life.
Read the full article: New Protocol Helps Better Treat Patients with Cardiogenic Shock (South Sound Business)
